EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $493,000 | -70.9% | 96,245 | -52.8% | 0.01% | -73.9% |
Q2 2021 | $1,694,000 | +94.5% | 203,838 | +103.9% | 0.02% | +21.1% |
Q1 2021 | $871,000 | -23.1% | 99,980 | -4.2% | 0.02% | -26.9% |
Q4 2020 | $1,132,000 | -55.9% | 104,321 | -34.8% | 0.03% | -69.8% |
Q2 2020 | $2,569,000 | +145.4% | 160,010 | +137.1% | 0.09% | +45.8% |
Q1 2020 | $1,047,000 | +72.2% | 67,500 | +39.2% | 0.06% | +90.3% |
Q2 2019 | $608,000 | – | 48,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |